Blackburn Kelly 4
4 · CervoMed Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
CervoMed Inc.CRVO
Blackburn Kelly
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2025-02-04+27,000→ 27,000 totalExercise: $2.30Exp: 2035-02-04→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025.